STABLE PHARMACEUTICAL COMPOSITIONS OF EDARAVONE
The present invention relates to liquid pharmaceutical compositions of edaravone. More specifically, stable solutions of edaravone for enteral administration are provided, wherein the composition is stable for extended period of time. The present invention further relates to stable solutions of edar...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | KORE, Girish YENDA, Parvateesam SUBBAPPA, Praveen PILLAI, Sumitra DUBE, Sushant PAWAR, Abhijit LOHAR, Jagdish BALASUBRAMANIAN, Satheesh |
| description | The present invention relates to liquid pharmaceutical compositions of edaravone. More specifically, stable solutions of edaravone for enteral administration are provided, wherein the composition is stable for extended period of time. The present invention further relates to stable solutions of edaravone, methods for their administration, processes for their production, and use of these compositions for treatment of diseases treatable by edaravone.
La présente invention concerne des compositions pharmaceutiques liquides d'édaravone. Plus particulièrement, l'invention concerne des solutions stables d'édaravone pour une administration entérale, la composition étant stable pendant une durée prolongée. La présente invention concerne en outre des solutions stables d'édaravone, des procédés pour leur administration, des processus pour leur production, et l'utilisation de ces compositions pour le traitement de maladies pouvant être traitées par l'édaravone. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2024172852A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2024172852A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2024172852A13</originalsourceid><addsrcrecordid>eNrjZNAPDnF08nFVCPBwDPJ1dHYNDfF0dvRRcPb3DfAP9gzx9PcLVvB3U3B1cQxyDPP3c-VhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHh_kYGRiaG5kYWpkaOhsbEqQIAseknFw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>STABLE PHARMACEUTICAL COMPOSITIONS OF EDARAVONE</title><source>esp@cenet</source><creator>KORE, Girish ; YENDA, Parvateesam ; SUBBAPPA, Praveen ; PILLAI, Sumitra ; DUBE, Sushant ; PAWAR, Abhijit ; LOHAR, Jagdish ; BALASUBRAMANIAN, Satheesh</creator><creatorcontrib>KORE, Girish ; YENDA, Parvateesam ; SUBBAPPA, Praveen ; PILLAI, Sumitra ; DUBE, Sushant ; PAWAR, Abhijit ; LOHAR, Jagdish ; BALASUBRAMANIAN, Satheesh</creatorcontrib><description>The present invention relates to liquid pharmaceutical compositions of edaravone. More specifically, stable solutions of edaravone for enteral administration are provided, wherein the composition is stable for extended period of time. The present invention further relates to stable solutions of edaravone, methods for their administration, processes for their production, and use of these compositions for treatment of diseases treatable by edaravone.
La présente invention concerne des compositions pharmaceutiques liquides d'édaravone. Plus particulièrement, l'invention concerne des solutions stables d'édaravone pour une administration entérale, la composition étant stable pendant une durée prolongée. La présente invention concerne en outre des solutions stables d'édaravone, des procédés pour leur administration, des processus pour leur production, et l'utilisation de ces compositions pour le traitement de maladies pouvant être traitées par l'édaravone.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240822&DB=EPODOC&CC=WO&NR=2024172852A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240822&DB=EPODOC&CC=WO&NR=2024172852A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KORE, Girish</creatorcontrib><creatorcontrib>YENDA, Parvateesam</creatorcontrib><creatorcontrib>SUBBAPPA, Praveen</creatorcontrib><creatorcontrib>PILLAI, Sumitra</creatorcontrib><creatorcontrib>DUBE, Sushant</creatorcontrib><creatorcontrib>PAWAR, Abhijit</creatorcontrib><creatorcontrib>LOHAR, Jagdish</creatorcontrib><creatorcontrib>BALASUBRAMANIAN, Satheesh</creatorcontrib><title>STABLE PHARMACEUTICAL COMPOSITIONS OF EDARAVONE</title><description>The present invention relates to liquid pharmaceutical compositions of edaravone. More specifically, stable solutions of edaravone for enteral administration are provided, wherein the composition is stable for extended period of time. The present invention further relates to stable solutions of edaravone, methods for their administration, processes for their production, and use of these compositions for treatment of diseases treatable by edaravone.
La présente invention concerne des compositions pharmaceutiques liquides d'édaravone. Plus particulièrement, l'invention concerne des solutions stables d'édaravone pour une administration entérale, la composition étant stable pendant une durée prolongée. La présente invention concerne en outre des solutions stables d'édaravone, des procédés pour leur administration, des processus pour leur production, et l'utilisation de ces compositions pour le traitement de maladies pouvant être traitées par l'édaravone.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNAPDnF08nFVCPBwDPJ1dHYNDfF0dvRRcPb3DfAP9gzx9PcLVvB3U3B1cQxyDPP3c-VhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHh_kYGRiaG5kYWpkaOhsbEqQIAseknFw</recordid><startdate>20240822</startdate><enddate>20240822</enddate><creator>KORE, Girish</creator><creator>YENDA, Parvateesam</creator><creator>SUBBAPPA, Praveen</creator><creator>PILLAI, Sumitra</creator><creator>DUBE, Sushant</creator><creator>PAWAR, Abhijit</creator><creator>LOHAR, Jagdish</creator><creator>BALASUBRAMANIAN, Satheesh</creator><scope>EVB</scope></search><sort><creationdate>20240822</creationdate><title>STABLE PHARMACEUTICAL COMPOSITIONS OF EDARAVONE</title><author>KORE, Girish ; YENDA, Parvateesam ; SUBBAPPA, Praveen ; PILLAI, Sumitra ; DUBE, Sushant ; PAWAR, Abhijit ; LOHAR, Jagdish ; BALASUBRAMANIAN, Satheesh</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2024172852A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2024</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>KORE, Girish</creatorcontrib><creatorcontrib>YENDA, Parvateesam</creatorcontrib><creatorcontrib>SUBBAPPA, Praveen</creatorcontrib><creatorcontrib>PILLAI, Sumitra</creatorcontrib><creatorcontrib>DUBE, Sushant</creatorcontrib><creatorcontrib>PAWAR, Abhijit</creatorcontrib><creatorcontrib>LOHAR, Jagdish</creatorcontrib><creatorcontrib>BALASUBRAMANIAN, Satheesh</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KORE, Girish</au><au>YENDA, Parvateesam</au><au>SUBBAPPA, Praveen</au><au>PILLAI, Sumitra</au><au>DUBE, Sushant</au><au>PAWAR, Abhijit</au><au>LOHAR, Jagdish</au><au>BALASUBRAMANIAN, Satheesh</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>STABLE PHARMACEUTICAL COMPOSITIONS OF EDARAVONE</title><date>2024-08-22</date><risdate>2024</risdate><abstract>The present invention relates to liquid pharmaceutical compositions of edaravone. More specifically, stable solutions of edaravone for enteral administration are provided, wherein the composition is stable for extended period of time. The present invention further relates to stable solutions of edaravone, methods for their administration, processes for their production, and use of these compositions for treatment of diseases treatable by edaravone.
La présente invention concerne des compositions pharmaceutiques liquides d'édaravone. Plus particulièrement, l'invention concerne des solutions stables d'édaravone pour une administration entérale, la composition étant stable pendant une durée prolongée. La présente invention concerne en outre des solutions stables d'édaravone, des procédés pour leur administration, des processus pour leur production, et l'utilisation de ces compositions pour le traitement de maladies pouvant être traitées par l'édaravone.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2024172852A1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | STABLE PHARMACEUTICAL COMPOSITIONS OF EDARAVONE |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T10%3A59%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KORE,%20Girish&rft.date=2024-08-22&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2024172852A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |